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Prostate Cancer

Treatment Planning

Treatment

Why SBRT for Treatment?

- Occurs when the cells grow out of control in the
prostate gland

Target Volumes:

Procedures:

- Computed tomography simulation (CT-sim), and
magnetic resonance imaging (MRI) are used to
set up treatment plans

- Patient should be simulated with full bladder
and empty rectum every treatment

- SBRT is noninvasive compared to other
treatment options such as surgery and
brachytherapy

- Most prostate cancers are slow to grow and
spread
- Develops in older men, average age of
diagnosis is 66
- Second most common cancer in American men
- 1 in 8 men have prostate cancer
(American Cancer Society, 2021, para. 2-4)

- Primary clinical target volume (CTV-P) could

include the whole prostate including seminal
vesicle, and are only included if believed to be
cancerous
- If seminal vesicle aren’t involved the CTV-P will
include typically 2cm of the seminal vesicles

(American Cancer Society, 2019, para. 1-2)

Types of Prostate Cancer
- Adenocarcinoma is the most common type
- Other types are small cell carcinomas,
neuroendocrine tumors, sarcomas, but these
are rare and unlikely

(Telkhade et al., 2021 p. 173)

- Planning Target Volumes (PTVs) are 3 to 5mm,
and in order to avoid the rectum the restrictions
tend to be stricter posteriorly (Kothari et al,, 2018, p. 8)
- PTVs can be broken down into high dose (HDPTV) and low dose (LD-PTVs)

(American Cancer Society, 2019, para. 5)

Treatment Plan: Contouring of PTVs

- The bladder and rectum restrictions help push
the bowel out the field and reduce radiation to
the bladder (Xia, et al., 2018, p. 175)
- A rectal balloon can be placed to immobilized
the rectum which allows for better separation
between anterior wall & prostate (Xia, et al., 2018, p.
172)

- SpaceOAR hydrogel can also be used to move
the rectum farther away from the prostate (Kothari
et al., 2018, p. 8)

Motion monitoring:
- Fiducial markers can be placed in order to track
movement using triggered imaging. When
movement is out of allowed parameters,
treatment will automatically stop until mark is
placed back into the right position (Xia ,et al., 2018,

- Prostate cancer has a low alpha/beta ratio
making it very sensitive to high doses of
radiation (Vanhanen, Poulsen, & Kapen, 2020 p. 58)
- Low rates of serve toxic events and good
biochemical control
- A study done on 2142 men with low-risk and
intermediate-risk prostate cancer, showed
SBRT treatment had good outcomes, low rate
of severe toxic events, and high rates had
biochemical control (Kishan et al., 2019, p. 1)
- Biochemical control rates were “less than 10%
for low-risk and favorable intermediate-risk
disease and just 15% for unfavorable
intermediate-risk disease” (Kishan et al., 2019, p. 8)
Biochemical Recurrence

p.172)

- Real time motion monitoring such as Calypso,
and RayPilot are used to continuously monitor
the prostate, which allows for beam-gating and
patient realignment to ensure proper areas are
being treated
- The use of continuous motion monitoring allows
for lower PTVs, and less exposure to OARs at
risk
(Vanhanen, Poulsen, & Kapen, 2020 p. 58)
`

(American Cancer Society, 2021, para. 3)

et al., 2018, p. 3)

- Commonly around 35 to 36.25 Gray (Gy).

- Radical prostatectomy

- 40 Gy is also an acceptable dose for treatment

- External beam radiotherapy

- Stereotactic body radiotherapy

(Xia, Godley, Shah, Videtic, & Suh, 2018, p. 176)

Organs at Risk (OARs):
(Kothari et al, 2018, p. 2)

Stereotactic Body Radiotherapy (SBRT)
- "administers very high doses of radiation, using
several beams of various intensities aimed at
different angles to precisely target the tumor”
(MD Anderson Cancer Center, n.d., para. 1)

-

Treatment is typically either one or five doses
once a day but can be different based on type
and location of the cancer (MD Anderson Cancer Center,
n.d., para. 3)

- Due to higher dose, there are less treatments
making SBRT more time and cost efficient (Kothari

Dose:

Treatment Options

- Brachytherapy

(Kishan et al., 2019, p. 6)

- Healthy organs and tissues that can be damaged
due to proximity of cancerous site treated

- Treatment is typically, around 5 fractions, 1 per
day
(Kothari et al., 2018, p. 5)
Treatment Plan: Isodose lines

- Bladder wall

Time efficiency leads to better satisfied
patients, because it shortens length of
treatment, a common complaint among patients
(Kothari et al., 2018, p. 3)

-

SBRT is a safe and efficient way to treat pelvicnode in node-positive prostate cancer according
to a study done on 60 lymph node positive
prostate cancer patients (Telkhade et al., 2021 p. 179)

Conclusion

- Rectum

- Stereotactic body radiotherapy is an acceptable
treatment for low-risk, intermediate-risk, and
lymph node positive prostate cancer

- Ureter
- Penile Bulb
- Femoral Head
- Colon

-

(Xia, et al., 2018, p. 180)

- Continuous motion monitoring of the prostate is
crucial to lower exposure to organs at risk, and
to lower planning target volumes

(Xia, et al., 2018, p. 177)

Misericordia University Printing Services

